Andronica Handie, DPM
Foot & Ankle Surgery · Tulsa, OKNPI 1376570812
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $146,959 of the $148,850 with a category attached, or 98.7%. F&a Foundation, LLC accounts for 99.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2021 at $35,786 and has fallen 65.8% since, to $12,256 in 2025. Among foot & ankle surgery clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 37 payments — averaging $4022.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F&a Foundation, LLC$148K
- Osteomed LLC$708
- Treace Medical Concepts, Inc.$158
- Polynovo North America LLC$26
- Integra Lifesciences Corporation$25
- Amgen$23
- plus $86 from 5 others
What the payments were for
- Royalty or licence$146,95999%
- Travel & lodging$1,7111%
- Food & beverage$1800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F&a Foundation, LLC | 24 | $147,825 |
| Osteomed LLC | 4 | $708 |
| Treace Medical Concepts, Inc. | 1 | $158 |
| Polynovo North America LLC | 1 | $26 |
| Integra Lifesciences Corporation | 1 | $25 |
| Amgen | 1 | $23 |
| SPR Therapeutics, Inc | 1 | $21 |
| AbbVie | 1 | $20 |
| Alafair Biosciences, Inc. | 1 | $18 |
| Bioventus LLC | 1 | $15 |
| Abbott | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXT-Other$688
- Lapiplasty System$158
How this compares
$148,850 in reported general payments places this provider in the 95th percentile of 71 foot & ankle surgery providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxepin Hcl | 36 | $5,290 |
| Ciclopirox | 39 | $1,002 |
| Methylprednisolone | 36 | $291 |
| Cephalexin | 38 | $270 |
| Allopurinol | 25 | $201 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $199 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $81 |
| Clindamycin Hcl | 11 | $71 |
| Gabapentin | 16 | $56 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tulsa
- Wesley StotlerTulsa$268K
- Brandon KitchensTulsa$19K
- James DaviesTulsa$15K
- Jason LiangTulsa$12K
- Nathan LashleyTulsa$6K
- Carl MillerTulsa$4K
- Abdurrahman KabaniTulsa$4K
- David StollerTulsa$3K
- Lateef LawalTulsa$1K
- Jill Jackson-SmithTulsa$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.